New Drugs
New approaches in managing drug overdosage and poisoning L F PRESCOTT 
Enhancement of drug removal from the body
The most important change in the enhancement of drug removal from the body has been a long overdue decline in the uncritical and indiscriminate use of forced diuresis and dialysis. These measures have a limited application in the management of poisoning, and a better understanding of the relevant physiological and pharmacokinetic principles has led to a more selective and realistic approach to their use. Forced alkaline diuresis is now largely restricted to moderate to severe poisoning with salicylates and phenobarbitone. It is also effective in removing the selective weedkiller 2,4-dichlorophenoxyacetic acid (2,4-D). There is a dearth of information concerning the efficacy of forced acid diuresis in poisoned patients and it is rarely used. Contrary to established teaching it does not usefully enhance the elimination of quinine after overdosage.
There are particular problems with the use of forced alkaline diuresis for salicylate poisoning. Like other anti-inflammatory drugs that inhibit prostaglandin synthesis, salicylate in overdosage causes retention of sodium and water and in some patients renal function is impaired. The resultant retention of fluid is potentially hazardous, and haemodilution causes a spurious fall in plasma salicylate concentrations, which gives a misleading impression of efficacy. The renal clearance of salicylate depends much more on urine pH than flow rate, and alkalinisation of the urine is therefore more important than attempts to force a diuresis. Naloxone is a competitive antagonist, and much larger doses are required for the full reversal of severe narcotic overdosage than those recommended by the manufacturer. The first adult dose should be not less than 1-2-1-6 mg intravenously and since it has a very short duration of action, repeated large doses may have to be given. Even larger doses may be required for severe poisoning with partial agonists which have a high affinity for receptors such as pentazocine. The recent introduction of the partial agonist buprenorphine is particularly worrying since its depressant effects cannot be readily reversed with naloxone. Naloxone has been reported to produce minor but variable arousal in some patients with benzodiazepine or ethanol intoxication, but there are no indications for its use in such circumstances. It may produce a transient acute withdrawal reaction in narcotic addicts.
N-acetylcysteine and methionine fdr paracetamol poisoning One of the most important developments in the management of poisoning has been the recent introduction of sulphydryl compounds such as N-acetylcysteine and methionine for the treatment of paracetamol poisoning. The major complication of paracetamol poisoning is acute hepatic necrosis, and this is caused by the formation of a highly reactive intermediate metabolite that is normally removed by conjugation with hepatic reduced glutathione. Liver damage after paracetamol overdosage occurs only when glutathione becomes depleted, and these protective agents probably act mainly by facilitating glutathione synthesis. Paracetamol poisoning was first treated successfully with cysteamine in 1973, but this agent has since been abandoned because of its toxicity and intravenous Nacetylcysteine is currently the treatment of choice.
Paracetamol is rapidly metabolised, and treatment must be started within 8-10 hours of ingestion to be effective. The protective effect falls off increasingly rapidly after this time, and treatment after 15 hours is not only ineffective but potentially dangerous. Most unselected patients referred to hospital after overdosage of paracetamol are not at risk of appreciable liver damage. Without specific treatment, only about 8% develop severe liver damage with a raised plasma asparate or alanine aminotransferase activity above 1000 IU/1, about 10% develop acute renal failure, and 1-2% die in hepatic failure. It is therefore essential to identify the few patients who require treatment, and this can be done only by emergency estimation of the plasma paracetamol concentration, since apart from nausea and vomiting there are no specific early clinical symptoms of severe intoxication. Treatment is indicated in patients with plasma paracetamol concentrations above a line on a semilogarithmic graph joining plots of 200 Cug/ml at four hours and 30 stg/ml at 15 hours. N-acetylcysteine appears to be more effective than methionine, and intravenous administration is essential because most severely poisoned patients develop nausea and vomiting within a few hours of ingestion of the paracetamol. N-acetylcysteine may rarely cause a minor transient allergic reaction, and methionine given late may precipitate or aggravate hepatic failure.
No form of late treatment (after 15 hours) has been shown to reduce the severity of liver damage or prevent hepatic failure.
Recent claims for the efficacy of late charcoal haemoperfusion for paracetamol poisoning must be viewed with caution. In one report haemoperfusion was started in seven patients on average 23 hours after the drug was taken, and the mean amount removed was 2-4 g. One patient died in hepatic failure and as judged by the plasma bilirubin concentration and prothrombin time ratio five developed severe liver damage. The amounts of paracetamol removed in the other two patients were only 0-38 and 0-36 g (equivalent to less than one tablet).
Physostigmine for anticholinergic poisoning
Physostigmine is a short acting reversible cholinesterase inhibitor that has been used with enthusiasm in some quarters for the reversal of intoxication with anticholinergics, notably the tricyclic antidepressants. It is given in the form of physostigmine salicylate, usually intravenously. While it can undoubtedly reverse coma and delirium induced by these drugs its effects are short lived, and the dose must be carefully titrated. Unfortunately, it may cause convulsions, and excess cholinergic activity can cause serious complications including asystole. Furthermore, there is no good evidence that physostigmine reverses the serious cardiac arrhythmias with conduction defects and the myocardial depression associated with severe tricyclic antidepressant poisoning. The use of physostigmine cannot therefore be recommended.
Glucagon for poisoning with beta-blocking drugs
Severe intoxication with beta-blockers such as propranolol and oxprenolol may produce bradycardia, hypotension, and gross myocardial depression with cardiogenic shock. In the latter circumstances the officially recommended treatment with atropine and isoprenaline is virtually useless. Atropine has no effect, and very large doses of the specific antagonist isoprenaline have to be given. The dose has to be carefully titrated, and in the meantime the patient may die. The use of glucagon may avoid these problems. Glucagon is a cardiac stimulant, its action is not inhibited by beta-blockade, and unlike isoprenaline in excessive dosage it does not cause cardiac arrhythmias. Initial intravenous bolus injections of 5-10 mg of glucagon may be followed by infusion at a rate sufficient to maintain an adequate cardiac output. Hyperglycaemia does not seem to be a problem, but vomiting may occur.
Immunotherapy
The administration of specific antibodies to bind and inactivate a drug or poison at the sites of action is an interesting new development in the treatment of poisoning that is still in its infancy. It is expensive and probably only practicable with agents such as digoxin and paraquat, which produce toxicity at low tissue concentrations. Severe digoxin poisoning has been treated successfully with Fab fragments of sheep digoxin-specific antibodies, but such treatment is not generally available in the United Kingdom. It is interesting to speculate on the possibility that patients who poison themselves repeatedly could be "immunised" against the toxic effects of their favourite drugs and poisons. discontinued after five deaths and five recurrences had occurred in the no treatment group and no deaths or recurrences, or both, in the heparin treated group. There is no doubt that heparin is a highly effective anticoagulant and that it is the treatment of choice in acute venous thrombosis and embolism-unless thrombolytic treatment is preferred.
Heparin should be continued for seven to 10 days and should be overlapped with oral anticoagulants for four to five days, not just the 48 hours which is so commonly practised. The use of oral anticoagulants is also based largely on uncontrolled studies. This is hardly surprising when you think of the practical difficulties in conducting such a trial. Kakkar et al, however, compared eight patients given oral anticoagulants for six to nine months with six patients who received none.4
The former group showed better recanalisation on follow up phlebography. Pathological studies have shown that recanalisation may take very many months and that patients are likely to have recurrent episodes. It therefore seems logical to try to reduce the likelihood of recurrent thrombosis by treating with anticoagulants during this period, especially as one of the objectives should be to prevent the development of a post-thrombotic syndrome. My practice is to treat with oral anticoagulants and knee length stockings for at least six months and to continue longer if post-thrombotic swelling is still present.-C V RUCKLEY, consultant vascular surgeon, Edinburgh. What health hazards are associated with swimming in the Thames ?
Apart from the common hazards of drowning and trauma infection is the greatest danger. In the non-tidal reaches of the river the risks are slight, as the Thames Water Authority makes strenuous efforts to control the sewage effluents from upstream townships and any pathogens present will be well diluted. Trade and radioactive discharges are also carefully monitored. There is little danger from salmonella infections. Viruses may be present in infective doses, however, and swimmers should have the protection of poliomyelitis vaccine. I know of no cases of virus hepatitis from swimming in non-tidal waters, and Weil's disease is not likely to occur. Eye and ear infections are not a real hazard. In the tidal reaches adjoining canals and docks the water and river banks may be heavily polluted, and intestinal infections, viral diseases, together with eye and ear infections, could be a real hazard.-ANDREW B SEMPLE, emeritus professor of community and environmental health, Liverpool.
